|
1
|
Adams RH and Alitalo K: Molecular
regulation of angiogenesis and lymphangiogenesis. Nat Rev Mol Cell
Biol. 8:464–478. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Shibuya M: Vascular endothelial growth
factor (VEGF) and its receptor (VEGFR) signaling in angiogenesis: A
crucial target for anti- and pro-angiogenic therapies. Genes
Cancer. 2:1097–1105. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Page DJ, Thuret R, Venkatraman L,
Takahashi T, Bentley K and Herbert SP: Positive feedback defines
the timing, magnitude, and robustness of angiogenesis. Cell Rep.
27:3139–3151.e5. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bergers G and Benjamin LE: Tumorigenesis
and the angiogenic switch. Nat Rev Cancer. 3:401–410. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
De Bock K, Mazzone M and Carmeliet P:
Antiangiogenic therapy, hypoxia, and metastasis: Risky liaisons, or
not? Nat Rev Clin Oncol. 8:393–404. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Garcia J, Hurwitz HI, Sandler AB, Miles D,
Coleman RL, Deurloo R and Chinot OL: Bevacizumab
(Avastin®) in cancer treatment: A review of 15 years of
clinical experience and future outlook. Cancer Treat Rev.
86:1020172020. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gramatzki D, Roth P, Rushing EJ, Weller J,
Andratschke N, Hofer S, Korol D, Regli L, Pangalu A, Pless M, et
al: Bevacizumab may improve quality of life, but not overall
survival in glioblastoma: An epidemiological study. Ann Oncol.
29:1431–1436. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Dhaun N and Webb DJ: Endothelins in
cardiovascular biology and therapeutics. Nat Rev Cardiol.
16:491–502. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rosanò L, Spinella F and Bagnato A:
Endothelin 1 in cancer: Biological implications and therapeutic
opportunities. Nat Rev Cancer. 13:637–651. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jin X, Jeon HM, Jin X, Kim EJ, Yin J, Jeon
HY, Sohn YW, Oh SY, Kim JK, Kim SH, et al: The ID1-CULLIN3 axis
regulates intracellular SHH and WNT signaling in glioblastoma stem
cells. Cell Rep. 16:1629–1641. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Park MH, Kim AK, Manandhar S, Oh SY, Jang
GH, Kang L, Lee DW, Hyeon DY, Lee SH, Lee HE, et al: CCN1
interlinks integrin and hippo pathway to autoregulate tip cell
activity. Elife. 8:e460122019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lee SY, Choi SH, Lee MS, Kurmashev A, Lee
HN, Ko YG, Lee K, Jeong S, Seong J, Kang JH and Kim H: Retraction
fibers produced by fibronectin-integrin α5β1 interaction promote
motility of brain tumor cells. FASEB J. 35:e219062021. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Urup T, Staunstrup LM, Michaelsen SR,
Vitting-Seerup K, Bennedbæk M, Toft A, Olsen LR, Jønson L,
Issazadeh-Navikas S, Broholm H, et al: Transcriptional changes
induced by bevacizumab combination therapy in responding and
non-responding recurrent glioblastoma patients. BMC Cancer.
17:2782017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ferrara N: Pathways mediating
VEGF-independent tumor angiogenesis. Cytokine Growth Factor Rev.
21:21–26. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gabbay E, Fraser J and McNeil K: Review of
bosentan in the management of pulmonary arterial hypertension. Vasc
Health Risk Manag. 3:887–900. 2007.PubMed/NCBI
|
|
18
|
Lugano R, Ramachandran M and Dimberg A:
Tumor angiogenesis: Causes, consequences, challenges and
opportunities. Cell Mol Life Sci. 77:1745–1770. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kim IK, Kim K, Lee E, Oh DS, Park CS, Park
S, Yang JM, Kim JH, Kim HS, Shima DT, et al: Sox7 promotes
high-grade glioma by increasing VEGFR2-mediated vascular
abnormality. J Exp Med. 215:963–983. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lasorella A, Benezra R and Iavarone A: The
ID proteins: Master regulators of cancer stem cells and tumour
aggressiveness. Nat Rev Cancer. 14:77–91. 2014. View Article : Google Scholar : PubMed/NCBI
|
